

The Power of RNA Amplified
Impact measured in billions.
YOUR CELLs’ vERY OWN COPY MACHINERY
Our platform leverages next-generation self-replicating RNA (srRNA) vectors. Once inside cells, the genetic code of our srRNA drives repeated production of natural RNA, resulting in outsized protein expression and durable therapeutic effect.
OUR SCIENCe

ENABLING BROAd APPLICATIONs FOR RNA TREATMENTs
Replicate is advancing a robust pipeline of srRNA treatments spanning several therapeutic areas, including infectious disease, oncology, and autoimmune disorders. Improved performance over linear mRNA lets us help even more patients.
PIPELINe



News & Publications
02.07.25
Press Releases
Replicate Bioscience Announces Publication of First-in-Human Data for Its Optimized srRNA Rabies Vaccine in Nature Communications
01.07.25
Publications & Presentations
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers
08.21.24
Press Releases
Replicate Bioscience to Participate in Upcoming Investor and Scientific Conferences